Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved Diabetic Macular Edema

  • Carl W. Baker, MD, FASRS
  • Video
  • Published 2019

Carl W. Baker, MD interviewed by Aleksandra Rachitskaya, MD


Related

  • Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA

    Diana V Do, MD, FASRS

    Annual Meeting Talks

    2022

  • Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

    Chirag D. Jhaveri, MD, FASRS

    Updates from the Field

    2022

  • Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study

    John W Hinkle, MD

    Updates from the Field

    2020

Category: Diabetic Retinopathy

  • Diabetic Retinopathy
  • Anti-VEGF Agents
  • Diabetic Macular Edema
  • clinical trials
  • DRCR

See more

  • Updates from the Field
  • Carl W. Baker, MD, FASRS
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists5315 North Clark Street, Suite 311, Chicago, Illinois 60640(312) 578-8760 phoneinfo@asrs.org
© 2026 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.